Table 1:
The effects of GCs on angiogenesis in particular solid tumors.
| Cancer | GC subtype | Species | Effect on angiogenesis | Other effects | Ref |
|---|---|---|---|---|---|
| Breast cancer | TA | Rabbit | Down-regulation | - | [29] |
| Breast cancer | Cortisol | Mouse | Up-regulation | - | [30] |
| Prostate cancer | DEX | Mouse | Down-regulation | - | [31] |
| Prostate cancer | GC signaling pathway | Human | Up-regulation | - | [32] |
| Bladder cancer | DEX, PRED | Cell line | Down-regulation | - | [33] |
| Bladder cancer | DEX | Mouse | Down-regulation | Decrease the effectiveness of chemotherapy | [34] |
| GBM | DEX | Human | None | Decrease the effectiveness of radiotherapy and chemotherapy | [35] |
| GBM | Mife (Antagonist of GC) | Mouse | Down-regulation | - | [36] |
| Melanoma | DX8 | Mouse | Down-regulation | - | [39] |
| Melanoma | PLP | Cell line | Down-regulation | - | [40] |
| Melanoma | HYC16 | Mouse | Down-regulation | - | [41] |
| Colon cancer | DEX | Cell line | Down-regulation | - | [42] |
| Colon cancer | LCL-PLP | Mouse | Down-regulation | - | [43] |
| Liver cancer | Hydrocortisone | Rat | Down-regulation | - | [44] |
| Liver cancer | DEX | Mouse | Down-regulation | - | [45] |
| Lung cancer | DEX | Mouse | Down-regulation | - | [46] |
| Lung cancer | DEX | Mouse | Down-regulation | - | [47] |